Peer-reviewed veterinary case report
Imaging changes in dog head and neck tumors during radiotherapy
By Rødal, Jan et al.·Published in Acta oncologica (Stockholm, Sweden)·2013·Department of Medical Physics·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy.
- Species:
- dog
Plain-English summary
Three dogs with head and neck tumors underwent a special type of radiation therapy called intensity-modulated radiotherapy (IMRT). During their treatment, the veterinarians used advanced imaging techniques to monitor changes in the tumors' blood flow and metabolism. They found that while two of the dogs showed increased blood flow to the tumors, only one dog had a noticeable decrease in metabolic activity after treatment. This suggests that while some tumors may respond well to radiation, others might not show clear signs of improvement. The imaging methods used could help vets assess how well the treatment is working right at the clinic.
People also search for: dog head and neck tumor treatment · canine radiotherapy response · monitoring dog tumor during treatment
Abstract
Radiotherapy causes alterations in tumor biology, and non-invasive early assessment of such alterations may become useful for identifying treatment resistant disease. The purpose of the current work is to assess changes in vascular and metabolic features derived from functional imaging of canine head and neck tumors during fractionated radiotherapy. Material and methods. Three dogs with spontaneous head and neck tumors received intensity-modulated radiotherapy (IMRT). Contrast-enhanced cone beam computed tomography (CE-CBCT) at the treatment unit was performed at five treatment fractions. Dynamic (18)FDG-PET (D-PET) was performed prior to the start of radiotherapy, at mid-treatment and at 3-12 weeks after the completion of treatment. Tumor contrast enhancement in the CE-CBCT images was used as a surrogate for tumor vasculature. Vascular and metabolic tumor parameters were further obtained from the D-PET images. Changes in these tumor parameters were assessed, with emphasis on intra-tumoral distributions. Results. For all three patients, metabolic imaging parameters obtained from D-PET decreased from the pre- to the inter-therapy session. Correspondingly, for two of three patients, vascular imaging parameters obtained from both CE-CBCT and D-PET increased. Only one of the tumors showed a clear metabolic response after therapy. No systematic changes in the intra-tumor heterogeneity in the imaging parameters were found. Conclusion. Changes in vascular and metabolic parameters could be detected by the current functional imaging methods. Vascular tumor features from CE-CBCT and D-PET corresponded well. CE-CBCT is a potential method for easy response assessment when the patient is at the treatment unit.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/23879646/